Health News Releases

  • Today October 14
September 20, 09:45
Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries
Takeda (TOKYO:4502/NYSE: TAK) today committed JPY4.6 billion (Approx. USD 32 million) to five new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to i
September 19, 14:35
Medidata Recognized as a Leader in Everest Group’s Inaugural Electronic Data Capture PEAK Matrix® Assessment
Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group's first-ever PEAK Matrix® Asses
September 18, 15:15
Viromed Medical AG Plans to Acquire All Shares of ActivCell Group AG by Way of a Capital Increase Against Contribution in Kind with Exclusion of Subscription Rights
Viromed Medical AG (Ticker: VMED (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Feqs-cockpit.com%2Fcgi-bin%2Ffncls.ssp%3Ffn%3Dredirect%26url%3D03003d462bf07ae5fbd5a9dd7d755919%26app
September 18, 13:55
Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54122668&newsitemid=20240917957215&lan=en-US&anchor=Parse+Biosciences&index=1&md
September 18, 12:10
Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex
Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), today announces the sale of its subsidiary Vectura Group Ltd. (Vectura) to Molex Asia Holdings Ltd., and
September 18, 11:45
Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today it will be showcasing updates from across its industry-leading dermatology portfolio at the 33rd European Academy of Der
RNA THERAPIES GLOBAL CLINICAL TRIAL LANDSCAPE INFOGRAPHIC (Graphic: Business Wire)
September 18, 09:45
Transforming the Future of Medicine with RNA-Based Therapies
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
September 13, 15:35
MicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth
MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. Thi
September 13, 14:30
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
ITM Isotope Technologies Munich SE (ITM) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DknxVWFX97-AJVcLZDmqPUgpwJEhTXICkW7WWecPUpZ99eWRx-Db
Evan L. Tzanis, Chief Operating Officer and EVP of R&D, Neuraptive Therapeutics, Inc. (Photo: Busine
September 13, 13:40
Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair
Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for accelerated development for patients with peripheral nerv
September 13, 11:50
Novotech Unveils 2024 Report on Global Gastric Cancer Clinical Trials and Cutting-Edge Therapeutics
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
September 13, 09:55
Novotech Wins Prestigious Brandon Hall Gold Award for CRA Monitoring Simulation Program under the category of Best Competencies and Skill Development
Novotech, a leading full-service clinical Contract Research Organization (CRO), is proud to announce that its Clinical Research Associate (CRA) Monitoring Simulation Program has been recognized with t
September 13, 08:55
Merck Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced presentations showcasing the long-term safety profile, sustained efficacy data, and
Dr. Yooni Kim, Managing Director APAC, Novotech (Photo: Business Wire)
September 12, 13:50
Novotech Appoints Dr. Yooni Kim as a New Executive Position of Managing Director for APAC to Strengthen Global Expansion
Novotech, the leading global biotech Contract Research Organization (CRO), is pleased to announce the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific
(Graphic: Business Wire)
September 11, 17:20
Novotech Honored with Frost & Sullivan’s 2024 Best Practices Company of the Year Award for Leadership in Biotech CRO Services
Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been awarded the prestigious 2024 Global Company of the Year Award by Frost & Sullivan
September 11, 11:05
CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients
CorFlow Therapeutics AG (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.corflow.com&esheet=54114953&newsitemid=20240910783655&lan=en-US&anchor=CorFlow+Therapeutics+AG&index=1&md5
Masimo SafetyNet® and Saint-Denis Hospital Center, Delafontaine (France) (Photo: Business Wire)
September 11, 09:40
Saint-Denis Hospital Center in France Implements Masimo SafetyNet® Telemonitoring to Facilitate Early Discharge of Premature Newborns from the Hospital
Masimo (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.masimo.com&esheet=54118830&newsitemid=20240908136612&lan=en-US&anchor=Masimo&index=1&md5=34c96fb7c39ca290fc395f6f1f3b2eb9)
September 10, 16:11
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced the appointment of Grégoire Franoux, M.B.A.,
September 06, 10:40
Novotech Releases 2024 Report on Pancreatic Cancer Clinical Trials and Drug Development
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
Left: Controller (MLC-AC0-P*) / Right: Detector (MLC-AD240A-P*) / Bottom: Sensor module (MLC-AS240A-
September 05, 14:15
PHC Launches LiCellMo™ Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies
PHC Corporation Biomedical Division (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.phchd.com%2Fglobal%2Fphc&esheet=54116517&newsitemid=20240903521355&lan=en-US&anchor=PHC+Corpo
Jason Monteleone, newly appointed president and CEO of Avania. (Photo: Business Wire)
September 05, 11:15
Avania Appoints Recognized CRO and MedTech Industry Leader, Jason Monteleone, as New President and CEO
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54116875&newsitemid=20240904978746&lan=en-US&anchor=Avania&index=1&md5=42bb77e18075e818ffddfc
Histotripsy patient Marie and her husband Steve after Marie’s histotripsy treatment of her liver tum
September 04, 16:10
HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials
HistoSonics, (www.histosonics.com), the developer and manufacturer of the Edison® Histotripsy System, announced today the publication of the company’s pivotal clinical trials data in Radiology (https:
EDT device (Photo: Business Wire)
September 04, 14:35
Rigaku: Novel Electron Density Topography Technology to Reveal Biological Macromolecules’ Properties
Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), has developed a te
August 30, 08:39
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the first patient has been dosed in the Phase III MyClad trial (NCT06463587 (https:/
August 29, 15:50
Galderma Successfully Issued an Inaugural CHF 500 Million Bond
Galderma Group AG (SWX:GALD): NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION Galderma succe
25 per page50 per page75 per page100 per page